• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种脑源性神经营养因子单倍型与强迫症的治疗反应相关。

A brain-derived neurotrophic factor haplotype is associated with therapeutic response in obsessive-compulsive disorder.

作者信息

Real Eva, Gratacòs Mònica, Soria Virginia, Escaramís Geòrgia, Alonso Pino, Segalàs Cinto, Bayés Mònica, de Cid Rafael, Menchón José M, Estivill Xavier

机构信息

OCD Clinical and Research Unit, Instituto de Salud Carlos III, Department of Psychiatry, Bellvitge University Hospital, Barcelona, Spain.

出版信息

Biol Psychiatry. 2009 Oct 1;66(7):674-80. doi: 10.1016/j.biopsych.2009.05.017. Epub 2009 Jul 9.

DOI:10.1016/j.biopsych.2009.05.017
PMID:19589503
Abstract

BACKGROUND

Several clinical and genetic studies have focused on the role of brain-derived neurotrophic factor (BDNF) in the pathophysiology of various mental disorders. Recent lines of evidence regarding the network hypothesis of treatment outcome point towards the involvement of BDNF variants in the pharmacologic response in mood disorders (MD). Furthermore, there is strong evidence of a role for the serotonergic system in the pathophysiology and treatment of OCD, and upregulation of BDNF has been observed with various classes of antidepressants, including selective serotonin reuptake inhibitors (SSRI). Thus, we hypothesized that the BDNF gene might also be associated with treatment outcome in OCD.

METHODS

We performed a single-marker and haplotype association study of eight tag single nucleotide polymorphisms in the BDNF genomic region and related this to pharmacologic response in a sample of 131 OCD patients.

RESULTS

We found an association for a haplotype containing two single nucleotide polymorphisms that have previously been reported to be associated with treatment outcome in MD (rs908867 and rs1491850).

CONCLUSIONS

Our results support the hypothesis that the BDNF gene is involved in the response to psychopharmacologic treatment even though these preliminary findings await replication in a follow-up sample.

摘要

背景

多项临床和遗传学研究聚焦于脑源性神经营养因子(BDNF)在各种精神障碍病理生理学中的作用。近期有关治疗结果网络假说的一系列证据表明,BDNF变异体参与了心境障碍(MD)的药物反应。此外,有强有力的证据表明血清素能系统在强迫症的病理生理学和治疗中发挥作用,并且在包括选择性5-羟色胺再摄取抑制剂(SSRI)在内的各类抗抑郁药治疗过程中均观察到BDNF上调。因此,我们推测BDNF基因可能也与强迫症的治疗结果相关。

方法

我们对BDNF基因组区域的8个标签单核苷酸多态性进行了单标记和单倍型关联研究,并将其与131例强迫症患者样本的药物反应相关联。

结果

我们发现一个包含两个单核苷酸多态性的单倍型存在关联,这两个单核苷酸多态性先前已被报道与心境障碍的治疗结果相关(rs908867和rs1491850)。

结论

我们的结果支持BDNF基因参与精神药物治疗反应这一假说,尽管这些初步发现有待在后续样本中进行重复验证。

相似文献

1
A brain-derived neurotrophic factor haplotype is associated with therapeutic response in obsessive-compulsive disorder.一种脑源性神经营养因子单倍型与强迫症的治疗反应相关。
Biol Psychiatry. 2009 Oct 1;66(7):674-80. doi: 10.1016/j.biopsych.2009.05.017. Epub 2009 Jul 9.
2
Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder.对脑源性神经营养因子(BDNF)和神经营养酪氨酸激酶2(NTRK2)基因进行广泛的基因分型,确定了针对强迫症的保护性单倍型。
Biol Psychiatry. 2008 Mar 15;63(6):619-28. doi: 10.1016/j.biopsych.2007.06.020. Epub 2007 Sep 19.
3
A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders.一种脑源性神经营养因子(BDNF)单倍型与心境障碍的抗抑郁治疗结果相关。
Pharmacogenomics J. 2008 Apr;8(2):101-12. doi: 10.1038/sj.tpj.6500460. Epub 2007 May 15.
4
Serotonergic functioning as measured by the loudness dependence of auditory evoked potentials is related to a haplotype in the brain-derived neurotrophic factor (BDNF) gene.通过听觉诱发电位的响度依赖性测量的5-羟色胺能功能与脑源性神经营养因子(BDNF)基因中的一个单倍型相关。
J Psychiatr Res. 2010 Jun;44(8):541-6. doi: 10.1016/j.jpsychires.2009.11.006. Epub 2009 Dec 9.
5
Genetic susceptibility to obsessive-compulsive hoarding: the contribution of neurotrophic tyrosine kinase receptor type 3 gene.强迫性囤积症的遗传易感性:神经营养性酪氨酸激酶受体3型基因的作用
Genes Brain Behav. 2008 Oct;7(7):778-85. doi: 10.1111/j.1601-183X.2008.00418.x. Epub 2008 Jul 28.
6
A genetic family-based association study of OLIG2 in obsessive-compulsive disorder.一项基于遗传家族的强迫症中OLIG2基因关联研究。
Arch Gen Psychiatry. 2007 Feb;64(2):209-14. doi: 10.1001/archpsyc.64.2.209.
7
Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.血管内皮生长因子(VEGFA)基因单核苷酸多态性的单倍型分析与重度抑郁症的抗抑郁治疗反应
Psychiatry Res. 2009 Sep 30;169(2):113-7. doi: 10.1016/j.psychres.2008.06.028. Epub 2009 Aug 22.
8
Brain-derived neurotrophic factor (BDNF) plasma levels in drug-naïve OCD patients are lower than those in healthy people, but are not lower than those in drug-treated OCD patients.药物初治强迫症患者的脑源性神经营养因子(BDNF)血浆水平低于健康人群,但不低于药物治疗的强迫症患者。
J Affect Disord. 2011 Sep;133(1-2):305-10. doi: 10.1016/j.jad.2011.04.002. Epub 2011 May 25.
9
Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder.早发性强迫症中定位和功能候选基因SLC1A1/EAAC1的关联测试。
Arch Gen Psychiatry. 2006 Jul;63(7):778-85. doi: 10.1001/archpsyc.63.7.778.
10
Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.脑源性神经营养因子 Val66Met 多态性与埃及精神分裂症患者的强迫症状。
J Psychiatr Res. 2012 Jun;46(6):762-6. doi: 10.1016/j.jpsychires.2012.03.007. Epub 2012 Apr 21.

引用本文的文献

1
BDNF signaling in context: From synaptic regulation to psychiatric disorders.脑源性神经营养因子信号通路:从突触调节到精神疾病
Cell. 2022 Jan 6;185(1):62-76. doi: 10.1016/j.cell.2021.12.003. Epub 2021 Dec 27.
2
Response to Fluvoxamine in the Obsessive-Compulsive Disorder Patients: Bayesian Ordinal Quantile Regression.强迫症患者对氟伏沙明的反应:贝叶斯有序分位数回归
Clin Pract Epidemiol Ment Health. 2021 Oct 15;17:146-151. doi: 10.2174/1745017902117010151. eCollection 2021.
3
Pharmacogenetics of Obsessive-Compulsive Disorder: An Evidence-Update.
强迫症的药物遗传学:证据更新。
Curr Top Behav Neurosci. 2021;49:385-398. doi: 10.1007/7854_2020_205.
4
Multi-level assessment of obsessive-compulsive disorder (OCD) reveals relations between neural and neurochemical levels.对强迫症(OCD)进行多层次评估揭示了神经和神经化学水平之间的关系。
BMC Psychiatry. 2020 Nov 25;20(1):559. doi: 10.1186/s12888-020-02913-5.
5
BDNF genetic variants and methylation: effects on cognition in major depressive disorder.脑源性神经营养因子基因变异与甲基化:对重度抑郁症认知的影响。
Transl Psychiatry. 2019 Oct 21;9(1):265. doi: 10.1038/s41398-019-0601-8.
6
Do polygenic risk and stressful life events predict pharmacological treatment response in obsessive compulsive disorder? A gene-environment interaction approach.多基因风险和生活应激事件能否预测强迫症的药物治疗反应?一种基因-环境相互作用的方法。
Transl Psychiatry. 2019 Feb 4;9(1):70. doi: 10.1038/s41398-019-0410-0.
7
Evidence of associations between brain-derived neurotrophic factor (BDNF) serum levels and gene polymorphisms with tinnitus.脑源性神经营养因子(BDNF)血清水平及基因多态性与耳鸣之间关联的证据。
Noise Health. 2017 May-Jun;19(88):140-148. doi: 10.4103/nah.NAH_74_16.
8
No association between BDNF Val66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population.日本人群中脑源性神经营养因子Val66Met多态性与强迫症治疗反应之间无关联。
Neuropsychiatr Dis Treat. 2016 Mar 11;12:611-5. doi: 10.2147/NDT.S102100. eCollection 2016.
9
Animal models of obsessive-compulsive disorder: utility and limitations.强迫症的动物模型:效用与局限性
Neuropsychiatr Dis Treat. 2015 Aug 4;11:1939-55. doi: 10.2147/NDT.S62785. eCollection 2015.
10
Characterizing the role of brain derived neurotrophic factor genetic variation in Alzheimer's disease neurodegeneration.探讨脑源性神经营养因子基因变异在阿尔茨海默病神经退行性变中的作用。
PLoS One. 2013 Sep 26;8(9):e76001. doi: 10.1371/journal.pone.0076001. eCollection 2013.